Docket

41209

Pharmascience Inc. v. Janssen Inc., et al.

(Federal) (Civil) (By Leave)

(Sealing order) (Certain information not available to the public)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2024-12-16 Certificate of counsel (attesting to record), (Letter Form), 24A, (Printed version filed on 2024-12-23) Pharmascience Inc.
2024-12-16 Certificate (on limitations to public access), (Letter Form), 23B, (Printed version filed on 2024-12-23) Pharmascience Inc.
2024-12-16 Appellant's book of authorities, (Book Form), New cover pages for the paper copies are required, Completed on: 2024-12-16, (Printed version filed on 2024-12-23) Pharmascience Inc.
2024-12-16 Appellant's record, (Book Form), CONFIDENTIAL and RESTRICTED

24 Volumes

, Completed on: 2024-12-17, (Printed version filed on 2024-12-23)
Pharmascience Inc.
2024-12-16 Appellant's factum, (Book Form), Completed on: 2024-12-16 Pharmascience Inc.
2024-12-11 Letter advising the parties of tentative hearing date and filing deadlines (Leave granted), Within the timeframe of May 12 - 23, 2025
2024-12-10 Appeal hearing
2024-11-28 Notice of change of counsel, (Printed version due on 2024-12-05) Janssen Inc.
2024-10-21 Certificate (on limitations to public access), Form 23B, (Printed version filed on 2024-10-22) Pharmascience Inc.
2024-10-21 Notice of appeal, Missing:
-Proof of service (rec'd 2024-10-21)
-Form 23B (rec'd 2024-10-21), Completed on: 2024-10-21, (Printed version filed on 2024-10-22)
Pharmascience Inc.
2024-09-19 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2024-09-19 Judgment on leave sent to the parties
2024-09-19 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-205-22, 2024 FCA 23, dated February 1, 2024, is granted with costs in the cause.
Granted, with costs in the cause
2024-07-29 All materials on application for leave submitted to the Judges, for consideration by the Court
2024-05-21 Certificate (on limitations to public access), (Letter Form), 23B;, (Printed version filed on 2024-05-28) Pharmascience Inc.
2024-05-21 Applicant's reply to respondent's argument, (Book Form), Completed on: 2024-05-28, (Printed version filed on 2024-05-28) Pharmascience Inc.
2024-05-10 Notice of name, (Letter Form), (Printed version filed on 2024-05-10) Janssen Inc.
2024-05-10 Certificate (on limitations to public access), (Letter Form), 23B;, (Printed version filed on 2024-05-10) Janssen Inc.
2024-05-10 Certificate (on limitations to public access), (Letter Form), 23A;, (Printed version filed on 2024-05-10) Janssen Inc.
2024-05-10 Respondent's response on the application for leave to appeal, (Book Form), SEALED/RESTRICTED
Redacted copy filed 05/10/2024

Cover pages wrong colour, new covers requested (Rec'd 06-21-2024), Completed on: 2024-07-25, (Printed version due on 2024-05-17)
Janssen Inc.
2024-04-10 Letter acknowledging receipt of an incomplete application for leave to appeal, FILE OPENED 2024-04-10;
2024-04-02 Book of authorities, (Book Form), Completed on: 2024-06-14, (Printed version filed on 2024-04-08) Pharmascience Inc.
2024-04-02 Notice of name, (Letter Form), (Printed version filed on 2024-04-08) Pharmascience Inc.
2024-04-02 Certificate (on limitations to public access), (Letter Form), 23B;, (Printed version due on 2024-04-09) Pharmascience Inc.
2024-04-02 Certificate (on limitations to public access), (Book Form), 23A;, (Printed version due on 2024-04-09) Pharmascience Inc.
2024-04-02 Application for leave to appeal, (Book Form), CONFIDENTIAL/RESTRICTED
Redacted copy filed 04/02/2024
Missing:
-Filing fees-rec'd 04/10/2024, Completed on: 2024-04-10, (Printed version filed on 2024-04-08)
Pharmascience Inc.